FLEXDYM, the material revolution for microfluidics

ended

Eden Microfluidics specializes in advanced materials and microfabrication solutions for microfluidics, and uses its expertise to develop innovative solutions for MedTech, CleanTech, Cosmetics and Pharma. Eden’s initial market, microfluidic systems, is emerging from R&D labs into commercialisation. In the last few years, key applications benefited from microfluidic breakthroughs, accelerating growth. These applications (PCR chips, Point of Care testing, …) are driving a dynamic microfluidic devices market, showing a 18% CAGR2017-2022, currently at $2.5B in 2017 and expected to reach almost US$6B in 2022. Yet, microfluidics is still very dependent on prototyping materials and methods, which can't be commercialized easily. Eden Microfluidics has patented the first polymer for microfluidics, the only one that permits easy transition from prototyping to commercialization. With this polymer, and its microfabrication companion, Eden is poised to engage with all customers: prototypers, manufacturers and providers. The vision of Eden Microfluidics is to become the leader in microfluidic systems and to do so, it envisions a « factory of the future » with proprietary advanced materials for microfluidics, microfabrication machines and design services for its end-users. With it, Eden will design, create and produce microfluidic systems for Market 2 (MedTech), Market 3 (CleanTech), and even beyond. With the SME instrument, Eden Microfluidics will establish additional markets that could be reached with new formulation of advanced materials, variant of its first product: Flexdym.